Arcus Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Arcus Biosciences, Inc. (RCUS) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.150.130.210.500.170.190.26
Short-Term Investments0.830.630.800.350.560.000.00
Cash & Short-Term Investments0.980.761.010.500.730.190.26
Accounts Receivable0.030.040.040.750.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.030.020.010.010.000.00
Total Current Assets1.020.831.071.260.740.190.26
Non-Current Assets
Property, Plant & Equipment (Net)0.050.050.140.030.020.010.01
Long-Term Investments0.010.110.130.180.010.000.00
Other Non-Current Assets0.070.110.010.120.010.000.00
Total Non-Current Assets0.130.260.280.330.040.010.02
Total Assets1.151.101.351.590.770.200.27
Current Liabilities
Accounts Payable0.020.020.020.010.020.010.01
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.100.060.070.050.030.000.00
Deferred Revenue0.090.090.100.100.070.000.00
Other Current Liabilities0.110.000.000.050.000.000.00
Total Current Liabilities0.230.180.190.170.120.020.02
Non-Current Liabilities
Long-Term Debt0.050.000.000.120.020.000.00
Other Non-Current Liabilities0.160.140.020.120.000.010.00
Total Non-Current Liabilities0.440.450.500.580.150.020.02
Total Liabilities0.670.630.690.750.270.040.04
Stockholders' Equity
Common Stock1.621.311.211.120.000.000.00
Retained Earnings-1.13-0.85-0.54-0.28-0.33-0.21-0.12
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Additional Paid-in Capital0.000.000.001.120.830.370.36
Shares Outstanding0.090.080.070.070.000.000.00
Total Stockholders' Equity0.490.460.660.840.500.160.23
Total Liabilities & Equity1.151.101.351.590.770.200.27